Respiratory Trials·org

Infection control · Selective decontamination

de Smet 2009 randomised trial

Decontamination of the digestive tract and oropharynx in ICU patients

de Smet 2009 trial design and results
Design Cluster-randomised crossover trial
Treatment Selective decontamination of the digestive tract (SDD), or selective oropharyngeal decontamination (SOD)
Control Standard care
Population 5939 ICU patients: 1990 standard care, 1904 SOD, 2045 SDD
Follow-up 28 days
Primary endpoint 28-day mortality
Result Crude 28-day mortality was 27.5% with standard care, 26.6% with SOD and 26.9% with SDD. After adjustment, mortality was reduced by an estimated 3.5 percentage points with SDD and 2.9 percentage points with SOD.
Secondary endpoints Bacteraemia, antibiotic resistance, ICU length of stay

In an ICU population in which the mortality rate associated with standard care was 27.5% at day 28, the rate was reduced by an estimated 3.5 percentage points with SDD and by 2.9 percentage points with SOD.

The trial authors, in the published abstract

How it has aged

Persuasive in the Netherlands and never adopted widely elsewhere, because the benefit depends on a low background prevalence of resistant organisms. SuDDICU later tested it internationally and found nothing, which largely settles the question outside that setting.

Publications

Decontamination of the digestive tract and oropharynx in ICU patients

de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009 Jan 1;360(1):20-31.

  • Estimated 3.5 percentage point mortality reduction with SDD after adjustment
  • Crude mortality similar across groups
  • Conducted in a setting with low antibiotic resistance